For the quarter ending 2026-03-31, DTIL has $143,891K in assets. $67,790K in debts. $99,370K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 99,370 | 110,823 | 44,870 | 62,242 |
| Assets held for sale | - | 0 | 126 | 140 |
| Accounts receivable | 4,000 | 0 | 4 | 0 |
| Marketable securities | 1,814 | 4,762 | 0 | 0 |
| Contract asset | - | 0 | 0 | 0 |
| Prepaid expenses | 3,503 | 3,110 | 5,857 | 7,450 |
| Other current assets | 6 | 45 | 848 | 427 |
| Total current assets | 108,693 | 118,740 | 51,705 | 70,259 |
| Restricted cash | 26,477 | 26,330 | 26,342 | 22,564 |
| Total property, equipment and software | - | 30,117 | - | - |
| Less accumulated depreciation and amortization | - | 28,692 | - | - |
| Note receivablenet | - | 0 | 5,370 | 5,730 |
| Property, equipment, and softwarenet | 1,183 | 1,425 | 2,026 | 2,356 |
| Intangible assetsnet | 1,127 | 1,166 | 985 | 605 |
| Right-of-use assetsnet | 5,464 | 5,805 | 6,138 | 6,462 |
| Investment in equity securities | 744 | 744 | 744 | 744 |
| Other assets | 203 | 206 | 200 | 208 |
| Total assets | 143,891 | 154,416 | 93,510 | 108,928 |
| Deferred revenue | - | 0 | 6,248 | 5,989 |
| Current liabilities of discontinued operations | - | 0 | 885 | 885 |
| Accounts payable | 944 | 296 | 1,340 | 1,121 |
| Accrued compensation | 1,140 | 4,747 | 3,157 | 2,450 |
| Accrued research and development expenses | 3,256 | 1,714 | 1,297 | 991 |
| Lease liabilities | 1,557 | 1,507 | 1,458 | 1,411 |
| Other current liabilities | 858 | 649 | 611 | 721 |
| Total current liabilities | 7,755 | 8,913 | 14,996 | 13,568 |
| Loan payable | 22,419 | 22,404 | 22,374 | 22,354 |
| Deferred revenue | - | 0 | 19,957 | 20,225 |
| Lease liabilities | 4,490 | 4,897 | 5,296 | 5,680 |
| Warrant liability | 22,802 | 15,695 | 4,026 | 2,847 |
| Contract liabilities | 10,000 | 10,000 | 10,000 | 10,000 |
| Other noncurrent liabilities | 324 | 259 | 227 | 200 |
| Total liabilities | 67,790 | 62,168 | 76,876 | 74,874 |
| Common stock 0.000005 par value 200,000,000 shares authorized as of march 31, 2026 and december 31, 2025 25,832,913 shares issued and 25,805,898 shares outstanding as of march 31, 2026 24,115,346 shares issued and 24,088,425 shares outstanding as of december 31, 2025 | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 623,681 | 621,387 | 565,906 | 561,554 |
| Accumulated deficit | -546,629 | -528,188 | -548,321 | -526,549 |
| Treasury stock | 952 | 952 | 952 | 952 |
| Total stockholders equity | 76,101 | 92,248 | 16,634 | 34,054 |
| Total liabilities and stockholders equity | 143,891 | 154,416 | 93,510 | 108,928 |
PRECISION BIOSCIENCES INC (DTIL)
PRECISION BIOSCIENCES INC (DTIL)